- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩417,000.00
7D
8.5%
1Y
-37.7%
Samsung BiologicsLtd
Market Cap: ₩74.5t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,609,000.00
7D
9.0%
1Y
2.5%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
8.1%
1Y
18.7%
JW Shinyak
Market Cap: ₩127.4b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,280.00
7D
17.6%
1Y
54.5%
JW Holdings
Market Cap: ₩280.9b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,060.00
7D
6.8%
1Y
18.7%
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩90,500.00
7D
13.4%
1Y
-8.4%